John A. Jenkins

Articles by this author

Busting Trusts, Breaking with Tradition

Requests in FOIAengine Show Groups Watching the FTC When the Federal Trade Commission joined the Justice Department last month in announcing new merger guidelines, two years in the making, the...

Collateral Damage Follows A Medical Leap

FOIAengine Lines Up the Players in a Huge Patent Fight When the Food and Drug Administration announced three weeks ago the approval of two milestone treatments for sickle cell disease,...

Orso Sees a Bear. Is AI the Next Big...

Another Short Seller Hits FOIAengine’s Radar It gets our attention when a short seller hits FOIAengine’s radar for the first time.  This week, we’re talking about Nathan Koppikar – Nate,...

Who Doesn’t Like Gary Gensler?

FOIAengine Finds SEC Chair in a Harsh Spotlight You’ve probably seen Rep. Patrick McHenry (R-NC), whether you know it or not.   For a few weeks last month, he was one of the...

Will the Feds Classify Marijuana as a “Safe” Drug?

In FOIAengine, Media Requests Seek the Answer When word leaked in late August that the Department of Health and Human Services recommended that marijuana should no longer be considered a dangerous drug,...

Savvy Social Media Causes Problems for the FDA

In FOIAengine, a Slew of Requests About Ivermectin Robert Califf headed up the Food and Drug Administration during the last year of the Obama Administration.  By the time Califf spun...